ClinicalTrials.gg
CompletedNCT02895581LEMPMARUpdated Sep 9, 2016

Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy

An observational study in Progressive Multifocal Leukoencephalopathy, sponsored by Fondation Ophtalmologique Adolphe de Rothschild. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-09-09.

Sponsored by Fondation Ophtalmologique Adolphe de Rothschild · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
34
Ages
18 Years and older
Sex
All
01

Study summary

Retrospective medical chart review of HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

02

Conditions studied

  • Progressive Multifocal Leukoencephalopathy
03

In context

Leukoencephalopathy, Progressive Multifocal

29 studies on the registry are indexed under Leukoencephalopathy, Progressive Multifocal; 7 are open to participants now.

This study's enrollment of 34 is below the median of 96 across 12 observational studies indexed under Leukoencephalopathy, Progressive Multifocal.

Browse Leukoencephalopathy, Progressive Multifocal studies →

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild is the lead sponsor of 316 studies on the registry; 78 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • infected patients
  • Diagnosed with progressive multifocal leukoencephalopathy
  • Minimal follow-up of one year OR patient deceased less than one year after diagnosis

Exclusion criteria

Exclusion Criteria:

  • Loss of follow-up within 12 months after diagnosis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
34 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Rankin score

    Time frame: 12 months after diagnosis of leukoencephalopathy

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2006 and a primary completion of Jan 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2016
First posted
Sep 9, 2016
Start
Jan 2006
Primary completionActual
Jan 2015
Last update
Sep 9, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02895581
Responsible party
Sponsor
First posted
Sep 9, 2016
Start date
Jan 2006
Primary completion
Jan 2015
Last update
Sep 9, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion